PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, School of Medicine, University of Washington, Seattle, United States.\', \'Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.\', \'Benaroya Research Institute at Virginia Mason, Seattle, United States.\', \'Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.\', \'Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, Albuquerque, United States.\', \'Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, United States.\', \'Department of Microbiology, School of Medicine, University of Washington, Seattle, United States.\', \'Department of Microbiology and Immunology, University of Texas Medical Center, Galveston, United States.\', \'Department of Basic Sciences, College of Osteopathic Medicine, Touro University Nevada, Henderson, United States.\', \'Department of Infectious Disease, Virginia Mason Medical Center, Seattle, United States.\', \'Department of Medicine, Section of Infectious Diseases, University of Washington, Seattle, United States.\', \'Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, United States.\', \'Center for Immunity and Immunotherapies, Seattle Children\'s Research Institute, Seattle, United States.\', \'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7554/eLife.71047e71047
?:hasPublicationType
?:journal
  • eLife
is ?:pmid of
?:pmid
?:pmid
  • 34342578
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.121
?:rankingScore_hIndex
  • 74
is ?:relation_isRelatedTo_publication of
?:title
  • Endomembrane targeting of human OAS1 p46 augments antiviral activity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all